Arrivent Biopharma, Inc. Share Price: AVBP (Arrivent Biopharma, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Arrivent Biopharma, Inc. share price today?

Accepted Answer

Arrivent Biopharma, Inc. (AVBP) share price today is {{live_price}}.

Question 2

Can Indians buy Arrivent Biopharma, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Arrivent Biopharma, Inc. (AVBP) from India.

With INDmoney, you can buy Arrivent Biopharma, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Arrivent Biopharma, Inc. at zero transaction cost.

Question 3

How can I buy Arrivent Biopharma, Inc. shares from India?

Accepted Answer

It is very easy to buy Arrivent Biopharma, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Arrivent Biopharma, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Arrivent Biopharma, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Arrivent Biopharma, Inc. stocks?

Accepted Answer

To start investing in Arrivent Biopharma, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Arrivent Biopharma, Inc.

Accepted Answer

Today’s highest price of Arrivent Biopharma, Inc. (AVBP) is {{1_rba_end}}.

Today’s lowest price of Arrivent Biopharma, Inc. (AVBP) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Arrivent Biopharma, Inc.

Accepted Answer

Today's market capitalisation of Arrivent Biopharma, Inc. AVBP is 899.4M

Question 8

What is the 52 Week High and Low Range of Arrivent Biopharma, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Arrivent Biopharma, Inc. is down from its 52 Week High?

Accepted Answer

Arrivent Biopharma, Inc. (AVBP) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Arrivent Biopharma, Inc. is up from its 52 Week low?

Accepted Answer

Arrivent Biopharma, Inc. (AVBP) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Arrivent Biopharma, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Arrivent Biopharma, Inc.

Accepted Answer

Dr. Zhengbin  Yao Ph.D. is the current Chief Executive Officer (CEO) of Arrivent Biopharma, Inc..

Period	Arrivent Biopharma, Inc.	Index (Russel 2000)
3 Months	51.0%	0.0%
6 Months	39.35%	0.0%
1 Year	40.05%	0.0%
3 Years	40.05%	-22.3%

Profit Margin	0.0%
Operating Margin TTM	0.0%

Return On Assets TTM	0.0%
Return On Equity TTM	0.0%

Revenue TTM	0.0
Revenue Per Share TTM	0.0
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	0.0
Diluted Eps TTM	0.0
Quarterly Earnings Growth YOY	0.0

EPS Estimate Current Year	0.0
EPS Estimate Next Year	0.0
EPS Estimate Current Quarter	0.0

Arrivent Biopharma, Inc. (AVBP)

Performance

Returns

Highlights

Analyst Recommendation

Technicals Summary

Peers

Company Information

Discover More

FAQs

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Arrivent Biopharma, Inc.	28.78%	39.35%	40.05%	40.05%	40.05%
Regeneron Pharmaceuticals, Inc.	5.97%	16.25%	37.11%	69.18%	305.56%
Novo Nordisk A/s	9.99%	-3.52%	34.24%	158.74%	417.73%
Alnylam Pharmaceuticals, Inc.	-5.15%	64.67%	22.72%	31.08%	198.44%
Vertex Pharmaceuticals Incorporated	0.45%	14.0%	36.06%	143.5%	167.72%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Arrivent Biopharma, Inc.	NA	NA	NA	0.0	0.0	0.0	NA	NA
Regeneron Pharmaceuticals, Inc.	29.93	29.93	1.54	45.05	0.17	0.08	NA	261.41
Novo Nordisk A/s	44.01	44.01	1.98	3.44	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.55	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.57	0.32	-0.03	0.13	NA	57.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Arrivent Biopharma, Inc.	Buy	$899.4M	40.05%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$124.7B	305.56%	29.93	32.04%
Novo Nordisk A/s	Buy	$585.3B	417.73%	44.01	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$32.3B	198.44%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$120.9B	167.72%	32.84	-4.74%

Organization	Arrivent Biopharma, Inc.
Employees	40
CEO	Dr. Zhengbin Yao Ph.D.
Industry	Miscellaneous